<DOC>
	<DOCNO>NCT00934167</DOCNO>
	<brief_summary>The aim study verify , clinical examination doppler , non-inferiority drug test ( heparin sodium 5.000UI/0.25 mL - HIPOLABOR ) relation drug compare ( heparin sodium 5.000USP/mL - APP ) preventing development venous thromboembolism ( VTE ) patient undergo surgery medium risk development pathology .</brief_summary>
	<brief_title>Efficacy Sodium Heparin Prophylaxis Venous Thromboembolism Surgical Patients</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Accept item describe IC sign two way ; Be age 18 60 ; Be alert need surgery antithrombotic prophylaxis ; Be classify `` moderate risk '' develop VTE , accord protocol prophylaxis deep vein thrombosis Brazilian Society Angiology Vascular Surgery . Acute coronary syndrome , make use anticoagulation ; Immobilization low limb due fracture , way consider high risk ; History recent stroke ; Patients high risk bleeding use heparin contraindicate ; General Surgery patient 60 year case patient high risk VTE ; general surgery patient 40 60 year additional risk factor development VTE ; Major amputation ; More orthopedic surgery ; Patients presurgical diagnosis malignant neoplasm ; Patients platelet level 100x109 / L ; Use anticoagulants 48 hour randomization ; Severe liver failure ; Be classify `` Low Risk '' `` high risk '' develop VTE , accord Maffei et al . ( 2005 ) ; Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>